About Erica Joyner

This author has not yet filled in any details.
So far Erica Joyner has created 410 blog entries.

Virginia

The Board of Pharmacy issued the following communication to licensees:

“In response to House Bill 2147, passed during the 2023 General Assembly Session, the Board of Pharmacy is reminding pharmacy personnel that federal laws require minimum standards in certain situations regarding patient translation services for prescription drugs. Specifically, pharmacy personnel are encouraged to review and consult with their management regarding the pharmacy’s compliance with the following federal laws: Title VI of the Civil Rights Act 1964 (42 U.S.C. 2000d) regarding discrimination based on race, color, or national origin by any program or activity receiving federal financial assistance; Section 504 of the Rehabilitation Act (29 U.S.C. § 794) regarding discrimination based on a disability from any program or activity receiving federal financial assistance; and Title III of the American with Disabilities Act (42 U.S.C. §§ 12181 to 12189; 28 C.F.R. Pt. 36) regarding discrimination at a place of public accommodation which includes a pharmacy. Please note the Board is unable to provide legal advice on this matter. However, additional information may be found in the Board of Pharmacy Report Regarding the Provision of Translated Directions for Use of Prescriptions submitted to the Virginia General Assembly on December 7, 2023.Please also be aware that the Board will adopt regulations and guidance by December 31, 2024, for accessible prescription labels to assist the blind, visually impaired, or otherwise print disabled as required by House Bill 516, passed during the 2024 General Assembly Session.”

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-07-18T12:56:15-04:00July 18, 2024|Virginia|

California

This week, SB 966 (Wiener) passed the Senate floor with a vote 39-0-1. SB 966 includes provisions that would prohibit the use of “spread pricing”. The bill would also provide other vital reforms, including requiring 100% pass-through of manufacturer rebates to plan sponsors to keep patient premiums low, prohibiting the steering of patients to PBM-affiliated pharmacies and requiring PBMs to obtain a license to operate in the state.

Also in California, SB 1365, legislation increasing the pharmacist to pharmacy technician to 1:4, was placed on the suspense file by the Senate Appropriations Committee and, subsequently, held in committee.

Also in California, the Department of Health Care Services posted the following alert and weekly report on the Medi-Cal Rx Web Portal.

Also in California, as a reminder, this will be the final opportunity to attest for the upcoming fiscal year 2024-2025. For details, review “Pharmacy Provider Dispensing Fee Self-Attestation”. All attestations must be received by May 31 to be accepted. Attestations will not be accepted after closing on May 31; there are no exceptions.

Also in California, the Medi-Cal Rx Diagnosis Crosswalk Navigation, video and the Medi-Cal Rx Reinstatement – Implementation of Reject Code 80 video have been published.

Finally in California, the Department of Health Care Services posted the following:

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-05-24T10:48:34-04:00May 24, 2024|California|

Florida

Gov. Ron DeSantis (R) signed HB 7072, the Tax Package for Fiscal Year 2024-25. The package provides $1.07 billion dollars in tax relief and includes several sales tax holidays that provide Floridians with substantial sales tax relief.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2024-05-24T10:47:39-04:00May 24, 2024|Florida|

Louisiana

The Senate passed HB 579, the PEP/PrEP bill, as amended by a vote of 38-0. The bill now goes back to the House to concur with the Senate amendments.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-05-24T10:46:31-04:00May 24, 2024|Louisiana|

Maine

The Board of Pharmacy posted the agenda for its next scheduled meeting on June 6.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2024-05-24T10:45:52-04:00May 24, 2024|Maine|

© National Association of Chain Drug Stores
All Rights Reserved | Privacy & Disclaimer

Go to Top